1.Long-term clinical and experimental/surface analytical studies of carbon/carbon maxillofacial implants.
Gyorgy SZABO ; Jozsef BARABAS ; Sandor BOGDAN ; Zsolt NEMETH ; Bela SEBOK ; Gabor KISS
Maxillofacial Plastic and Reconstructive Surgery 2015;37(10):34-
BACKGROUND: Over the past 30-40 years, various carbon implant materials have become more interesting, because they are well accepted by the biological environment. The traditional carbon-based polymers give rise to many complications. The polymer complication may be eliminated through carbon fibres bound by pyrocarbon (carbon/carbon). The aim of this study is to present the long-term clinical results of carbon/carbon implants, and the results of the scanning electron microscope and energy dispersive spectrometer investigation of an implant retrieved from the human body after 8 years. METHODS: Mandibular reconstruction (8-10 years ago) was performed with pure (99.99 %) carbon implants in 16 patients (10 malignant tumours, 4 large cystic lesions and 2 augmentative processes). The long-term effect of the human body on the carbon/carbon implant was investigated by comparing the structure, the surface morphology and the composition of an implant retrieved after 8 years to a sterilized, but not implanted one. RESULTS: Of the 16 patients, the implants had to be removed earlier in 5 patients because of the defect that arose on the oral mucosa above the carbon plates. During the long-term follow-up, plate fracture, loosening of the screws, infection or inflammations around the carbon/carbon implants were not observed. The thickness of the carbon fibres constituting the implants did not change during the 8-year period, the surface of the implant retrieved was covered with a thin surface layer not present on the unimplanted implant. The composition of this layer is identical to the composition of the underlying carbon fibres. Residual soft tissue penetrating the bulk material between the carbon fibre bunches was found on the retrieved implant indicating the importance of the surface morphology in tissue growth and adhering implants. CONCLUSIONS: The surface morphology and the structure were not changed after 8 years. The two main components of the implant retrieved from the human body are still carbon and oxygen, but the amount of oxygen is 3-4 times higher than on the surface of the reference implant, which can be attributed to the oxidative effect of the human body, consequently in the integration and biocompatibility of the implant. The clinical conclusion is that if the soft part cover is appropriate, the carbon implants are cosmetically and functionally more suitable than titanium plates.
Carbon
;
Follow-Up Studies
;
Human Body
;
Humans
;
Inflammation
;
Mandible
;
Mandibular Reconstruction
;
Mouth Mucosa
;
Oxygen
;
Polymers
;
Titanium
2.Novel genes in Human Asthma Based on a Mouse Model of Allergic Airway Inflammation and Human Investigations.
Gergely TEMESI ; Viktor VIRAG ; Eva HADADI ; Ildiko UNGVARI ; Lili E FODOR ; Andras BIKOV ; Adrienne NAGY ; Gabriella GALFFY ; Lilla TAMASI ; Ildiko HORVATH ; Andras KISS ; Gabor HULLAM ; Andras GEZSI ; Peter SARKOZY ; Peter ANTAL ; Edit BUZAS ; Csaba SZALAI
Allergy, Asthma & Immunology Research 2014;6(6):496-503
PURPOSE: Based on a previous gene expression study in a mouse model of asthma, we selected 60 candidate genes and investigated their possible roles in human asthma. METHODS: In these candidate genes, 90 SNPs were genotyped using MassARRAY technology from 311 asthmatic children and 360 healthy controls of the Hungarian (Caucasian) population. Moreover, gene expression levels were measured by RT PCR in the induced sputum of 13 asthmatics and 10 control individuals. t-tests, chi-square tests, and logistic regression were carried out in order to assess associations of SNP frequency and expression level with asthma. Permutation tests were performed to account for multiple hypothesis testing. RESULTS: The frequency of 4 SNPs in 2 genes differed significantly between asthmatic and control subjects: SNPs rs2240572, rs2240571, rs3735222 in gene SCIN, and rs32588 in gene PPARGC1B. Carriers of the minor alleles had reduced risk of asthma with an odds ratio of 0.64 (0.51-0.80; P=7x10(-5)) in SCIN and 0.56 (0.42-0.76; P=1.2x10(-4)) in PPARGC1B. The expression levels of SCIN, PPARGC1B and ITLN1 genes were significantly lower in the sputum of asthmatics. CONCLUSIONS: Three potentially novel asthma-associated genes were identified based on mouse experiments and human studies.
Alleles
;
Animals
;
Asthma*
;
Child
;
Gene Expression
;
Humans
;
Inflammation*
;
Logistic Models
;
Mice*
;
Odds Ratio
;
Polymerase Chain Reaction
;
Polymorphism, Single Nucleotide
;
Sputum